The groundbreaking treatment of the medication represents a significant advance in the management of type 2 diabetes. Unlike existing drugs, tirzepatide affects multiple pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide685523.mpeblog.com/76220906/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment